Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas

International Journal of Oncology

Volumn 33, Issue 4, 2008, Pages 783-790

  Gondi, Christopher S ^a   Dinh, Dzung H ^a   Gujrati, Meena ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Apoptosis; Caspase 9; Glioma; Matrix metalloproteinase 9; Receptor interacting protein; Urokinase type plasminogen activator receptor

Indexed keywords

APOPTOSOME; CARRIER PROTEIN; CASPASE 9; CYTOCHROME C; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GELATINASE B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RECEPTOR INTERACTING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL FRACTIONATION; CELL LEVEL; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRACELLULAR TRANSPORT; MOLECULAR MECHANICS; NICK END LABELING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

APOPTOSIS; BRAIN NEOPLASMS; CASPASE 9; CYTOSOL; DNA FRAGMENTATION; ENZYME ACTIVATION; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 9; MITOCHONDRIA; MODELS, BIOLOGICAL; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, CELL SURFACE;

EID: 54049113443     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000065     Document Type: Article

References (30)

1. Henson PM and Hume DA: Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 27: 244-250, 2006.
2. Muzio M: Signalling by proteolysis: death receptors induce apoptosis. Int J Clin Lab Res 28: 141-147, 1998.
3. van Horssen R, Ten Hagen TL and Eggermont AM: TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11: 397-408, 2006.
4. Lakka SS, Gondi CS, Dinh DH, Olivero WC, Gujrati M, Rao VH, Sioka C and Rao JS: Specific interference of uPAR and MMP-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomas. J Biol Chem 280: 21882-21892, 2005.
5. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998.
6. Napoli C, Lemieux C and Jorgensen R: Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2: 279-289, 1990.
7. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
8. Morris KV, Chan SW, Jacobsen SE and Looney DJ: Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305: 1289-1292, 2004.
9. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, John M, Kesavan V, Lavine G, Pandey RK, Racie T, Rajeev KG, Rohl I, Toudjarska I, Wang G, Wuschko S, Bumcrot D, Koteliansky V, Limmer S, Manobaran M and Vornlocher HP: Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173-178, 2004.
10. Gandhari M, Arens N, Majety M, Dorn-Beineke A and Hildenbrand R: Urokinase-type plasminogen activator induces proliferation in breast cancer cells. Int J Oncol 28: 1463-1470, 2006.
11. Park J, Song SH, Kim TY, Choi MC, Jong HS, Kim TY, Lee JW Kim NK, Kim WH and Bang YJ: Aberrant methylation of integrin alpha4 gene in human gastric cancer cells. Oncogene 23: 3474-3480, 2004.
12. Zhang L, Zhao ZS, Ru GQ and Ma J: Correlative studies on UPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer. World J Gastroenterol 12: 3970-3976, 2006.
13. van der Pluijm G, Sijmons B, Vloedgraven H, van der Bent C, Drijfhout JW, Verheijen J, Quax P, Karperien M, Papapoulos S and Lowik C: Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol 159: 971-982, 2001.
14. Wang XQ, Sun P and Paller AS: Gangliosides inhibit urokinase-type plasminogen activator (uPA)-dependent squamous carcinoma cell migration by preventing uPA receptor/alphabeta integrin/epidermal growth factor receptor interactions. J Invest Dermatol 124: 839-848, 2005.
15. Vial D, Monaghan-Benson E and Keown-Longo PJ: Coordinate regulation of fibronectin matrix assembly by the plasminogen activator system and vitronectin in human osteosarcoma cells. Cancer Cell Int 6: 8, 2006.
16. Adachi Y, Lakka SS, Chandrasekar N, Yanamandra N, Gondi CS, Mohanam S, Dinh DH, Olivero WC, Gujrati M, Tamiya T, Ohmoto T, Kouraklis G, Aggarwal B and Rao JS: Down-regulation of integrin alpha(v)beta(3) expression and integrin-mediated signaling in glioma cells by adenovirus-mediated transfer of antisense urokinase-type plasminogen activator receptor (uPAR) and sense p16 genes. J Biol Chem 276: 47171-47177, 2001.
17. Aguirre-Ghiso JA: Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21: 2513-2524, 2002.
18. Fernandez CA, Yan L, Louis G, Yang J, Kutok JL and Moses MA: The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11: 5390-5395, 2005.
19. Gong YL, Xu GM, Huang WD and Chen LB: Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. J Surg Oncol 73: 95-99, 2000.
20. Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M and Shiba M: Elevated levels of circulating plasma matrix metalloproteinase 9 in non-small cell lung cancer patients. Clin Cancer Res 5: 149-153, 1999.
21. Pereira AM, Strasberg-Rieber M and Rieber M: Invasion-associated MMP-2 and MMP-9 are up-regulated intracellularly in concert with apoptosis linked to melanoma cell detachment. Clin Exp Metastasis 22: 285-295, 2005.
22. Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3: 489-501, 2003.
23. Allen DL, Teitelbaum DH and Kurachi K: Growth factor stimulation of matrix metalloproteinase expression and myoblast migration and invasion in vitro. Am J Physiol Cell Physiol 284: C805-C815, 2003.
24. Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, Nirmala C, Lakka SS, Adachi Y, Kyritsis AP, Ali-Osman F, Sawaya R, Fuller GN and Rao JS: Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res 60: 6851-6855, 2000.
25. Wang ZB, Liu YQ and Cui YF: Pathways to caspase activation. Cell Biol Int 29: 489-496, 2005.
26. Chang HY and Yang X: Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev 64: 821-846, 2000.
27. Green D and Kroemer G: The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 8: 267-271, 1998.
28. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
29. Gondi CS, Kandhukuri N, Kondraganti S, Gujrati M, Olivero WC, Dinh DH and Rao JS: RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells. Mol Cancer Ther 5: 3197-3208, 2006.
30. Yanamandra N, Konduri SD, Mohanam. S, Dinh DH, Olivero WC, Gujrati M, Nicolson GL, Obeyeseke M and Rao JS: Down-regulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells. Clin Exp Metastasis 18: 611-615, 2001.